Login to Your Account

Cracking China’s market – via Taiwan – Neurovive moves to take Asian subsidiary public

By Dave Silver
Staff Writer

Wednesday, March 19, 2014

TAIPEI, TAIWAN – Neurovive Pharmaceutical AB’s Hong Kong-registered subsidiary, Neurovive Pharmaceutical Asia Ltd., has signed a financial services agreement with Yuanta Securities Co. Ltd. for the Taiwanese company to be its underwriter in a planned initial public offering (IPO) in Taiwan.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription